Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
OpSec Security has announced a COVID-19 testing kit authentication and traceability solution.
read more
Sorrel Medical announced the opening of a new manufacturing facility with state-of-the-art cleanroom facilities to accommodate manufacturing scalability of its wearable drug delivery devices.
read more
Omya has rebuilt and expanded its calcium carbonate production plant in Orgon, France, creating a substantially higher capacity for its functionalized calcium carbonate product platform, a new packaging line and an on-site warehouse.
read more
INTERPHEX, American Pharmaceutical Review, and Pharmaceutical Outsourcing announced the winners of the 2020 INTERPHEX Exhibitor Awards.
read more
Horizon Discovery Group announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines.
read more
Vetter has invested in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.
read more
Bellwyck has announced the completion of the company’s three-pronged strategic press-acquisition initiative.
read more
Lonza announced the establishment of a Center of Excellence for Dry Powder Inhaler drug product development at its OR site.
read more
Bionova Scientific has initiated construction of its new biologics manufacturing facility.
read more
Signant Health has announced the appointment of Roger Smith as Chief Executive Officer.
read more
SGS has received approval from FAMHP and has initiated the first site to begin a new clinical trial of a potential treatment for patients with COVID-19 related respiratory failure.
read more
Headlands Research announced its acquisition of two large CNS-focused clinical research centers; JEM Research Institute and Toronto Memory Program.
read more
Orchard Therapeutics and MolMed have extended their collaboration – initiated in April 2018 – for a period of five years through June 2025.
read more
LGC has announced the acquisition of The Native Antigen Company (NAC), a supplier of infectious disease antigens and antibodies.
read more
The FDA has been determining the safest and most appropriate time to resume prioritized domestic inspections of FDA-regulated facilities and other associated activities since we first announced postponement in March.
read more